|
|
A01586-1
|
BosterBio |
|
100ug/vial |
|
|
|
STJ24698
|
St John's Laboratory |
|
100 µl |
|
|
|
A01586
|
BosterBio |
|
100ug/200ul |
|
|
|
STJ70023
|
St John's Laboratory |
|
100 µg |
|
|
|
MBS8109145-01mL
|
MyBiosource |
|
0.1mL |
|
|
|
MBS8109145-5x01mL
|
MyBiosource |
|
5x0.1mL |
|
|
|
dAP-0027
|
Angio Proteomie |
|
50ug |
|
|
|
MBS421184-01mg
|
MyBiosource |
|
0.1mg |
|
|
|
MBS421184-5x01mg
|
MyBiosource |
|
5x0.1mg |
|
|
|
MBS1750675-01mg
|
MyBiosource |
|
0.1mg |
|
|
|
MBS1750675-5x01mg
|
MyBiosource |
|
5x0.1mg |
|
|
|
TA310072
|
Origene Technologies GmbH |
|
100 µl |
|
|
|
TA321099
|
Origene Technologies GmbH |
|
100 µl |
|
|
|
|
|
AMM05044G
|
Leading Biology |
|
0.1 mg |
|
|
|
STJ111002
|
St John's Laboratory |
|
100 µl |
|
|
|
STJ24699
|
St John's Laboratory |
|
100 µl |
|
|
|
STJ24700
|
St John's Laboratory |
|
100 µl |
|
|
|
PAab05582
|
Nova Lifetech |
|
100ug |
|
|
|
TA350235
|
Origene Technologies GmbH |
|
100 µl |
|
|
|
TA338377
|
Origene Technologies GmbH |
|
100 µl |
|
|
|
TA338965
|
Origene Technologies GmbH |
|
100 µl |
|
|
|
TA338966
|
Origene Technologies GmbH |
|
100 µl |
|
|
|
STJ71228
|
St John's Laboratory |
|
100 µg |
|
|
|
dAP-1129
|
Angio Proteomie |
|
50ug |
|
|
|
MBS421423-01mg
|
MyBiosource |
|
0.1mg |
|
|
|
MBS421423-5x01mg
|
MyBiosource |
|
5x0.1mg |
|
|
|
MBS2401916-005mL
|
MyBiosource |
|
0.05mL |
|
|
|
MBS2401916-5x005mL
|
MyBiosource |
|
5x0.05mL |
|
|
|
TA326975
|
Origene Technologies GmbH |
|
100 µg |
|
|
|
TA323606
|
Origene Technologies GmbH |
|
100 µl |
|
|
|
|
|
AMM05053G
|
Leading Biology |
|
0.1 mg |
|
|
|
|
|
YF-PA13357
|
Abfrontier |
|
50 ug |
|
|
|
YF-PA13358
|
Abfrontier |
|
100 ug |
|
|
|
YF-PA24211
|
Abfrontier |
|
50 ul |
|
|
|
YF-MA14382
|
Abfrontier |
|
100 ug |
|
|
|
MBS225141-005mL
|
MyBiosource |
|
0.05mL |
|
|
|
MBS225141-5x005mL
|
MyBiosource |
|
5x0.05mL |
|
|
|
|
|
|
|
|
|
|
|
E19-6282
|
EnoGene |
|
100μg/100μl |
|
|
|
CSB-PA015525KA01HU-
|
Cusabio |
|
each |
|
|
|
CSB-PA015525KA01HU-100ul
|
Cusabio |
|
100ul |
|
|
|
1-CSB-PA015525LA01HU
|
Cusabio |
|
|
|
|
|
|
|